1. Home
  2. GLBE vs ALKS Comparison

GLBE vs ALKS Comparison

Compare GLBE & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global-E Online Ltd.

GLBE

Global-E Online Ltd.

HOLD

Current Price

$31.92

Market Cap

6.3B

Sector

Technology

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$33.22

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLBE
ALKS
Founded
2013
1987
Country
Israel
Ireland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.7B
IPO Year
2021
1991

Fundamental Metrics

Financial Performance
Metric
GLBE
ALKS
Price
$31.92
$33.22
Analyst Decision
Buy
Strong Buy
Analyst Count
13
13
Target Price
$49.46
$42.85
AVG Volume (30 Days)
1.5M
2.1M
Earning Date
02-18-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.44
EPS
0.04
2.02
Revenue
$888,450,000.00
$1,521,338,000.00
Revenue This Year
$29.23
N/A
Revenue Next Year
$24.28
$23.22
P/E Ratio
$839.02
$16.50
Revenue Growth
31.57
1.08
52 Week Low
$26.64
$25.17
52 Week High
$63.69
$36.45

Technical Indicators

Market Signals
Indicator
GLBE
ALKS
Relative Strength Index (RSI) 30.92 54.54
Support Level $31.69 $33.04
Resistance Level $33.56 $35.34
Average True Range (ATR) 1.55 1.03
MACD -0.24 -0.21
Stochastic Oscillator 13.20 40.18

Price Performance

Historical Comparison
GLBE
ALKS

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: